Re:Balaji Srinivasan, who may run the FDA for Trump, hates t...
by edoloughlin on Monday January 16, 2017 @02:03PM
(#13412056)
Not-yet-approved implies that the research isn't finished. How are you going to 'intelligently' assess the risk?
[ Parent
| on HN ]
Re:Balaji Srinivasan, who may run the FDA for Trump, hates t...
by noobermin on Monday January 16, 2017 @02:07PM
(#13412094)
By getting sick and dying I suppose, but you before me, so I won't make the same mistake. I honestly can't think of any other alternative.
A ratings website is not a replacement for controlled experiment. The FDA and the current Pharma industry have problems, but this is in no way an intelligent alternative.
Re:Balaji Srinivasan, who may run the FDA for Trump, hates t...
by tlb on Monday January 16, 2017 @02:21PM
(#13412225)
There are several stages of research. For a sufficiently serious condition, it can make sense to take drugs that are only validated at a pre-clinical stage.
And there are many conclusions of finished research. A common conclusion is "cures problem A, but may cause problem B", and depending on A and B, those drugs can fail approval. But individuals may place different values on A and B.